Entecavir 70771-1019
Product NDC
70771-1019- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 10, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA206745
Need to source Entecavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Entecavir | .5 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Analog [EXT]Nucleoside Reverse Transcriptase Inhibitors [MoA]
Packaging Options(4)
100 TABLET, FILM COATED in 1 BOTTLE (70771-1019-1)
30 TABLET, FILM COATED in 1 BOTTLE (70771-1019-3)
10 BLISTER PACK in 1 CARTON (70771-1019-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1019-2)
90 TABLET, FILM COATED in 1 BOTTLE (70771-1019-9)